Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MLNK
2326
DELISTED
MeridianLink
MLNK
| $4.36M | ﹤0.01% |
235,177
-3,855
| -2% | -$74.5K |
|
|
ZIMV
2327
DELISTED
ZimVie
ZIMV
| $4.35M | ﹤0.01% |
403,124
-16,775
| -4% | -$220K |
|
2328
Southern Missouri Bancorp
SMBC
$858M
| $4.34M | ﹤0.01% |
83,448
-8,072
| -9% | -$456K |
|
|
KRMN
2329
Karman Holdings
KRMN
$7.31B
| $4.29M | ﹤0.01% |
+128,467
| New | +$4.15M |
|
2330
Hyster-Yale Materials Handling
HY
$662M
| $4.29M | ﹤0.01% |
103,328
-9,684
| -9% | -$482K |
|
2331
Mineralys Therapeutics
MLYS
$2.38B
| $4.29M | ﹤0.01% |
270,175
+55,269
| +26% | +$636K |
|
2332
Arbutus Biopharma
ABUS
$897M
| $4.27M | ﹤0.01% |
1,222,065
-136
| -0% | -$454 |
|
2333
iQIYI
IQ
$1.24B
| $4.26M | ﹤0.01% |
1,884,384
+1,341,745
| +247% | +$2.95M |
|
2334
Alcon
ALC
$33.9B
| $4.26M | ﹤0.01% |
44,829
+10,930
| +32% | +$981K |
|
2335
Ivanhoe Electric
IE
$1.69B
| $4.25M | ﹤0.01% |
732,032
+23,626
| +3% | +$150K |
|
2336
Consensus Cloud Solutions
CCSI
$687M
| $4.22M | ﹤0.01% |
182,844
-5,675
| -3% | -$146K |
|
|
SEZL
2337
Sezzle
SEZL
$6B
| $4.21M | ﹤0.01% |
120,661
-3,521
| -3% | -$149K |
|
|
FPI
2338
Farmland Partners
FPI
$434M
| $4.2M | ﹤0.01% |
376,468
+2,613
| +0.7% | +$30.1K |
|
2339
Aurinia Pharmaceuticals
AUPH
$2.07B
| $4.19M | ﹤0.01% |
521,416
-143,671
| -22% | -$1.16M |
|
|
ACCD
2340
DELISTED
Accolade Inc
ACCD
| $4.19M | ﹤0.01% |
600,382
-11,349
| -2% | -$76K |
|
2341
Bank of N.T. Butterfield & Son
NTB
$2.44B
| $4.19M | ﹤0.01% |
107,645
-70,712
| -40% | -$2.68M |
|
|
DAWN
2342
DELISTED
Day One Biopharmaceuticals
DAWN
| $4.19M | ﹤0.01% |
528,148
-7,353
| -1% | -$79.2K |
|
|
ENFN
2343
DELISTED
Enfusion, Inc.
ENFN
| $4.15M | ﹤0.01% |
372,252
+1,101
| +0.3% | +$12.2K |
|
|
FLOC
2344
Flowco Holdings
FLOC
$876M
| $4.15M | ﹤0.01% |
+161,659
| New | +$4.26M |
|
2345
D-Wave Quantum Inc. Common Stock
QBTS
$7.19B
| $4.14M | ﹤0.01% |
544,956
+223,672
| +70% | +$1.5M |
|
2346
National CineMedia
NCMI
$378M
| $4.14M | ﹤0.01% |
708,729
-20,186
| -3% | -$129K |
|
2347
Immunome
IMNM
$2.92B
| $4.13M | ﹤0.01% |
614,387
+157,135
| +34% | +$1.51M |
|
2348
DHT Holdings
DHT
$2.96B
| $4.13M | ﹤0.01% |
393,183
-136,418
| -26% | -$1.47M |
|
2349
Fulgent Genetics
FLGT
$510M
| $4.12M | ﹤0.01% |
243,979
+33,768
| +16% | +$575K |
|
2350
VanEck High Yield Muni ETF
HYD
$4.44B
| $4.12M | ﹤0.01% |
80,466
-248
| -0.3% | -$12.8K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.